Print Page  Close Window

Press Releases

Keyword Search
 
Current | Archive
DateTitle 
02/03/16OraSure Announces Record Revenues for Full-Year and Fourth Quarter 2015
BETHLEHEM, Pa., Feb. 03, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the full-year and fourth quarter ended December 31, 2015. Financial Highlights Consolidated net revenues for the fourth quarter of 2015 were $32.4 million, a 13% increase from the fourth quarter of 2014. Consolidated net revenues for the year ended December 31, 2015 ... 
Printer Friendly Version
01/13/16OraSure Technologies Earnings Conference Call Invitation
2015 Fourth Quarter Earnings Conference Call Wednesday, February 3, 2016, 5:00 p.m. ET BETHLEHEM, Pa., Jan. 13, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2015 fourth quarter financial results, 2016 first quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, February 3, 2016.   February 3, 2016 Schedule 4:00 p.m. ET 2015 fourth ... 
Printer Friendly Version
12/08/15DNA Genotek Inc. Appoints Microbiome Data Scientist as Advisor
Dan Knights, PhD, Brings Deep Experience in Microbiome Analysis and Biomarker Discovery OTTAWA, ON, December 8, 2015. DNA Genotek, a leading provider of sample collection kits and end-to-end services for human genomics, microbiome and infectious disease, today announced Dan Knights, PhD – an expert in machine learning and microbiome analysis – as a scientific advisor to the company. Dr. Dan Knights is a computational microbiologist and a leading authority in the application of machine learning... 
Printer Friendly Version
11/10/15OraSure Technologies to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
BETHLEHEM, Pa., Nov. 10, 2015 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Canaccord Genuity Medical Technology & Diagnostic Forum in New York City, New York. The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on November 19, 2015, at approxima... 
Printer Friendly Version
11/04/15OraSure Announces 2015 Third Quarter Financial Results
BETHLEHEM, Pa., Nov. 04, 2015 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the three and nine months ended September 30, 2015. Financial Highlights Consolidated net revenues for the third quarter of 2015 were $29.9 million, a 7% increase from the comparable quarter of 2014. Consolidated net revenues for the nine months ended September 30, 2... 
Printer Friendly Version
10/14/15OraSure Technologies Earnings Conference Call Invitation
2015 Third Quarter Earnings Conference Call  Wednesday, November 4, 2015, 5:00 p.m. ET BETHLEHEM, Pa., Oct. 14, 2015 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2015 third quarter financial results, 2015 fourth quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, November 4, 2015.  November 4, 2015 Schedule     4:00 p.m. ET ... 
Printer Friendly Version
09/29/15OraSure Technologies Provides Update on OraQuick Ebola Rapid Antigen Test Business
BARDA Exercises Contract Option for $7.2 Million in Additional Funding BETHLEHEM, Pa., Sept. 29, 2015 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, announced today that it has made significant progress regarding the commercialization of its OraQuick® Ebola Rapid Antigen Test. The Company announced that the Biomedical Advanced Research Development Authority (BARDA) of the U.S. Department of Health and... 
Printer Friendly Version
08/28/15OraSure Technologies Announces 2016 Annual Meeting Date
BETHLEHEM, Pa., Aug. 28, 2015 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that its 2016 Annual Meeting of Stockholders is scheduled to be held on Tuesday, May 17, 2016. Further details regarding the meeting will be provided at a later date. About OraSure Technologies OraSure Technologies is a leader in the development, manufacture and distribution of point-of-care diagnostic and collection devices and other technologies designed to detect or diagnose crit... 
Printer Friendly Version
08/05/15OraSure Announces 2015 Second Quarter Financial Results
BETHLEHEM, Pa., Aug. 5, 2015 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the three and six months ended June 30, 2015. Financial Highlights Consolidated net revenues for the second quarter of 2015 were a record $30.4 million, a 15% increase from the comparable quarter of 2014. Consolidated net revenues for the six months ended June 30, 2... 
Printer Friendly Version
08/04/15OraSure Technologies to Present at the Canaccord Genuity 35th Annual Growth Conference
BETHLEHEM, Pa., Aug. 4, 2015 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Canaccord Genuity 35th Annual Growth Conference in Boston, Massachusetts. The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak August 12, 2015, at approximately 2:00 PM Eastern ... 
Printer Friendly Version